MORGAN STANLEY PLC/PUT/STRYKER CORP./250/0.1/20.06.25 Share Price

Warrant

DE000ME032Q0

Market Closed - Börse Stuttgart 17:39:31 28/06/2024 BST
0.49 EUR -3.92% Intraday chart for MORGAN STANLEY PLC/PUT/STRYKER CORP./250/0.1/20.06.25
Current month-3.92%
1 month-5.77%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 0.49 -3.92%
27/06/24 0.51 +2.00%
26/06/24 0.5 -3.85%
25/06/24 0.52 +8.33%
24/06/24 0.48 -5.88%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 05:39 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME032Q
ISINDE000ME032Q0
Date issued 28/08/2023
Strike 250 $
Maturity 20/06/2025 (356 Days)
Parity 10 : 1
Emission price 2.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.92
Lowest since issue 0.41
Delta-0.1x
Omega 6.052
Premium28.02x
Gearing60.98x
Moneyness 0.7362
Difference Strike -90.25 $
Difference Strike %-36.10%
Spread 0.04
Spread %7.41%
Theoretical value 0.5200
Implied Volatility 30.80 %
Total Loss Probability 84.14 %
Intrinsic value 0.000000
Present value 0.5200
Break even 244.43 €
Theta-0.01x
Vega0.05x
Rho-0.03x

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus